We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DD:NYSEDuPont de Nemours, Inc. Analysis

Data as of 2026-03-11 - not real-time

$45.97

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DuPont de Nemours (DD) is trading at $45.97, comfortably above its 20‑day SMA of 49.25 but still below the 50‑day SMA of 45.87, indicating a mixed short‑term price signal. The RSI of 42 suggests the stock is neither overbought nor oversold, while the MACD histogram is sharply negative (-0.82) and the signal line is bearish, pointing to downward momentum. Volume has been decreasing, and the 30‑day volatility is high at 38%, which together raise the near‑term risk profile. Despite a bullish trend direction flag, the recent earnings call revealed a miss, with reported EPS of -$0.26 versus expectations of $0.43, adding pressure on the price.
Fundamentally, DD shows a trailing P/E of 219 due to a loss, yet the forward P/E contracts to a reasonable 18, reflecting improving earnings outlook. The DCF‑derived fair value of $438 implies the market is severely undervaluing the business, and analysts’ median target of $56.5 offers a modest 22% upside. The dividend yield of 1.74% is supported by a very low payout ratio of 6.8%, suggesting sustainability. With a strong‑buy consensus from 16 analysts, margin expansion expectations, and a solid dividend, the longer‑term case remains attractive despite short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Recent earnings miss and negative EPS
  • Bearish MACD histogram
  • Decreasing volume and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 18 indicating earnings improvement
  • Analyst consensus strong‑buy with median target $56.5
  • Margin expansion and modest upside potential

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far above current price
  • Sustainable dividend with low payout ratio
  • Diversified global exposure reducing concentration risk

Key Metrics & Analysis

Financial Health

Profit Margin-11.37%
P/E Ratio218.9
ROE0.52%
ROA1.86%
Debt/Equity24.48
P/B Ratio1.4
Op. Cash Flow$1.4B
Free Cash Flow$13.4B

Technical Analysis

TrendBullish
RSI42.1
Support$43.05
Resistance$52.66
MA 20$49.25
MA 50$45.87
MA 200$36.40
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$438.73
Target Price$56.13
Upside/Downside22.09%
GradeUndervalued
TypeBlend
Dividend Yield1.74%

Risk Assessment

Beta1.39
Volatility38.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.